Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

NCT02773355 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02773355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02773355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
May 16, 2016
Completion date
February 28, 2022
Enrollment
27 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

obesity